Technical Analysis for NVNO - enVVeno Medical Corporation

Grade Last Price % Change Price Change
F 3.37 -6.65% -0.24
NVNO closed down 6.65 percent on Wednesday, November 20, 2024, on 1.93 times normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Upper Bollinger Band Touch Strength 0.00%
50 DMA Resistance Bearish -6.65%
Crossed Above 20 DMA Bullish -6.65%
Pocket Pivot Bullish Swing Setup -6.65%
Wide Range Bar Range Expansion -6.65%
Gapped Up Strength -6.65%
Upper Bollinger Band Touch Strength -6.65%
20 DMA Resistance Bearish 1.81%
Pocket Pivot Bullish Swing Setup 1.81%

   Recent Intraday Alerts

Alert Time
10 DMA Support about 21 hours ago
Rose Above Upper Bollinger Band about 21 hours ago
2x Volume Pace about 21 hours ago
1.5x Volume Pace about 21 hours ago
Down 3% about 21 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

enVVeno Medical Corporation Description

enVVeno Medical is an Irvine, California based medical device company focused on the development of innovative bioprosthetic (tissue-based) solutions to improve the standard of care in the treatment of venous disease. The Company's lead product, the VenoValveĀ®, is a first-in-class implant being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). In healthy patients, valves inside the veins of the leg assist in propelling blood up the leg, and back to the heart and lungs. Affecting approximately 2.4 million people in the United States, CVI occurs when valves inside of the veins of the leg become damaged, resulting in the backwards flow of blood (reflux), blood pooling in the lower leg, increased pressure in the veins of the leg (venous hypertension) and in severe cases, venous ulcers that are difficult to heal and become chronic. Implanted into the femoral vein, the VenoValve is designed to act as a one-way valve, to help restore proper blood flow in the leg. The VenoValve is currently being evaluated in the SAVVE pivotal study with data expected in late 2022.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Vascular Disease Ulcer Veins Circulatory System Angiology Cardiovascular System Chronic Venous Insufficiency Insufficiency Venous Insufficiency Venous Ulcer

Is NVNO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.97
52 Week Low 3.012
Average Volume 163,623
200-Day Moving Average 4.88
50-Day Moving Average 3.69
20-Day Moving Average 3.42
10-Day Moving Average 3.45
Average True Range 0.20
RSI (14) 45.65
ADX 20.45
+DI 22.02
-DI 15.27
Chandelier Exit (Long, 3 ATRs) 3.15
Chandelier Exit (Short, 3 ATRs) 3.84
Upper Bollinger Bands 3.61
Lower Bollinger Band 3.24
Percent B (%b) 0.36
BandWidth 10.95
MACD Line -0.06
MACD Signal Line -0.08
MACD Histogram 0.0261
Fundamentals Value
Market Cap 44.88 Million
Num Shares 13.3 Million
EPS -2.14
Price-to-Earnings (P/E) Ratio -1.57
Price-to-Sales 0.00
Price-to-Book 2.30
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.89
Resistance 3 (R3) 3.93 3.80 3.80
Resistance 2 (R2) 3.80 3.67 3.78 3.77
Resistance 1 (R1) 3.58 3.58 3.52 3.54 3.75
Pivot Point 3.45 3.45 3.42 3.43 3.45
Support 1 (S1) 3.24 3.32 3.17 3.20 2.99
Support 2 (S2) 3.11 3.24 3.08 2.97
Support 3 (S3) 2.89 3.11 2.94
Support 4 (S4) 2.85